Aortic Endograft Market Report 2026

Aortic Endograft Market Overview

• Aortic Endograft market size has reached to $3.52 billion in 2025 • Expected to grow to $4.5 billion in 2030 at a compound annual growth rate (CAGR) of 5% • Growth Driver: Growing Prevalence Of Aortic Aneurysms Driving Market Growth Through Increased Demand For Minimally Invasive Vascular Repair • Market Trend: Revolutionary Medical Device For Aortic And Aortic Arch Repair • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Aortic Endograft Market?

An aortic endograft, or endovascular stent graft, is a minimally invasive device used to repair weakened areas of the aorta, the main artery that carries blood from the heart to the rest of the body. It is used as an alternative to traditional open surgery for repairing aortic aneurysms. The main products of aortic endografts are abdominal aortic grafts and thoracic aortic grafts. Abdominal aortic grafts are devices implanted in the abdominal aorta to treat aneurysms by reinforcing weakened arterial walls. The materials includes are metallic endograft and polymeric endograft, which follow procedures such as open surgical repair, and endovascular aneurysm repair (EVAR). It is used in hospitals, ambulatory surgical centers.

What Is The Aortic Endograft Market Growth Forecast?

The aortic endograft market size is expected to see steady growth in the next few years. It will grow to $4.5 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to growing aging population with vascular disorders, rising preference for endovascular procedures, expansion of personalized vascular implants, increasing investments in next-generation graft materials, growing demand for faster recovery surgical options. Major trends in the forecast period include increasing adoption of minimally invasive aneurysm repair, rising use of fenestrated and branched endografts, growing demand for customized stent graft designs, expansion of evar procedures, enhanced focus on long-term graft durability.

Global Aortic Endograft Market Segmentation

1) By Product: Abdominal Aortic Grafts, Thoracic Aortic Grafts 2) By Material: Metallic Endografts, Polymeric Endografts 3) By Procedure: Open Surgical Repair, Endovascular Aneurysm Repair (EVAR) 4) By End User: Hospitals, Ambulatory Surgical Centers Subsegments: 1) By Abdominal Aortic Grafts: Fenestrated Aortic Grafts, Branched Aortic Grafts, Conventional Aortic Grafts 2) By Thoracic Aortic Grafts: Stented Thoracic Aortic Grafts, Non-Stented Thoracic Aortic Grafts, Hybrid Thoracic Aortic Grafts

What Is The Driver Of The Aortic Endograft Market?

The growing prevalence of aortic aneurysms is expected to propel the growth of the aortic endograft market going forward. An aortic aneurysm is a localized and abnormal dilation or bulging of the aorta, which is the largest artery in the human body. The rise in the prevalence of aortic aneurysms is due to the increasing average age of the population alongwith the high incidence of associated conditions like hypertension and atherosclerosis. The growing prevalence of aortic aneurysms supports the aortic endograft by increasing demand for endovascular repair devices that provide minimally invasive alternatives to open surgery, reduce procedural risks, and improve patient recovery. For instance, in February 2023, according to Government Digital Service, a UK-based public sector information website, around 274,800 men were offered screening, with 79.0% receiving a conclusive screen and 1,794 aneurysms. Therefore, the growing prevalence of aortic aneurysms is driving the growth of the aortic aneurysm market.

Key Players In The Global Aortic Endograft Market

Major companies operating in the aortic endograft market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., LifeTech Scientific Corporation, MicroPort Scientific Corporation, CryoLife Inc., Endologix LLC, Braile Biomédica Indústria Comércio e Representações Ltda., Nano Endoluminal S.A., JOTEC GmbH, Lombard Medical Inc., Aptus Endosystems Inc., Lombardi SA, Cardiatis S.A., Endospan Ltd., Transcatheter Technologies GmbH, Vascutek Ltd.

Global Aortic Endograft Market Trends and Insights

Major companies operating in the aortic endograft market are developing innovative solutions, such as the castor-branched aortic stent graft system, to gain a competitive edge in the market. The castor-branched aortic stent graft system is a medical device used for minimally invasive repair of the aorta and aortic arch, particularly in cases of Stanford type B aortic dissection (TBAD). For instance, in August 2024, Terumo India, an India-based companyin medical technology, and the Indian subsidiary of Terumo Corporation, launched the TREO Stent-Graft System, an innovative solution for Endovascular Aneurysm Repair (EVAR). This advanced system is designed for the treatment of infrarenal abdominal aortic aneurysms in adults with appropriate anatomies and is the only EVAR graft to offer both suprarenal and infrarenal active fixation.

What Are Latest Mergers And Acquisitions In The Aortic Endograft Market?

In October 2025, Terumo Aortic, a US-based manufacturer of aortic endografts devices, partnered with Bentley, to conduct a groundbreaking clinical study in the aortic endograft market. Through this collaboration, Terumo Aortic and Bentley aim to advance clinical evidence, optimize device performance, and improve patient outcomes in complex aortic interventions. Terumo Aortic specializes in aortic and vascular solutions, while Bentley focuses on innovative cardiovascular technologies and clinical research support. Bentley is a US-based cardiovascular technology and balloon-expandable covered stents manufacturer.

Regional Outlook

North America was the largest region in the aortic endograft market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Aortic Endograft Market?

The aortic endograft market consists of revenues earned by entities by training programs, educational services, maintenance, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The aortic endograft market also includes sales of endoanchors and sealants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.